Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Community Study to Evaluate the Performance of COVID-19 Frequent Antigen Testing at Home Through Digital Health Reporting

NCT05884515 is registered in ClinicalTrials.gov with IDX20 Inc as lead sponsor.

NCT NCT05884515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05884515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Community Study to Evaluate the Performance of COVID-19 Frequent Antigen Testing at Home Through Digital Health Reporting
Lead sponsor
IDX20 Inc
Phase
Phase 1
Overall status
Unknown status
Start date
December 13, 2021
Completion date
November 21, 2023
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 respiratory infection